Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 217

Similar articles for PubMed (Select 8036706)

1.

Safety and efficacy of low dose simvastatin in cardiac transplant recipients treated with cyclosporine.

Vanhaecke J, Van Cleemput J, Van Lierde J, Daenen W, De Geest H.

Transplantation. 1994 Jul 15;58(1):42-5.

PMID:
8036706
2.

Evaluation of Serum Oxidized Low-Density Lipoprotein in Renal Transplant Recipients and Hemodialysis Patients and Relation With Involved Variables.

Soltani A, Argani H, Soleimani F, Rahimipour H, Akbarzadeh-Baghban A, Azizi T, Kazerouni F, Farshchian F.

Exp Clin Transplant. 2015 Jun 15. doi: 10.6002/ect.2014.0221. [Epub ahead of print]

PMID:
26086712
3.

Clinical evaluation of rosuvastatin in heart transplant patients with hypercholesterolemia and therapeutic failure of other statin regimens: short-term and long-term efficacy and safety results.

Barge-Caballero G, Barge-Caballero E, Marzoa-Rivas R, Paniagua-Martín MJ, Barrio-Rodríguez A, Naya-Leira C, Blanco-Canosa P, Grille-Cancela Z, Vázquez-Rodríguez JM, Crespo-Leiro MG.

Transpl Int. 2015 Apr 11. doi: 10.1111/tri.12585. [Epub ahead of print]

PMID:
25864881
4.

Downregulation of miR-146a, cyclooxygenase-2 and advanced glycation end-products in simvastatin-treated older patients with hyperlipidemia.

Yang ZX, Wang YZ, Jia BB, Mao GX, Lv YD, Wang GF, Yu H.

Geriatr Gerontol Int. 2015 Feb 27. doi: 10.1111/ggi.12472. [Epub ahead of print]

PMID:
25727911
5.

Evaluation of a classical unani pharmacopeial formulation safoof-e-muhazzil in hyperlipidemia: A randomized, standard controlled clinical study.

Jahangir U, Khan AA, Kapoor P, Jalees F, Urooj S.

J Pharm Bioallied Sci. 2014 Jul;6(3):167-79. doi: 10.4103/0975-7406.130975.

6.

Is your cholesterol drug putting you at risk for vision loss?

[No authors listed]

Harv Health Lett. 2013 Dec;39(2):8. No abstract available.

PMID:
24634971
7.

Association of simvastatin and hyperlipidemia with periodontal status and bone metabolism markers.

Magán-Fernández A, Papay-Ramírez L, Tomás J, Marfil-Álvarez R, Rizzo M, Bravo M, Mesa F.

J Periodontol. 2014 Oct;85(10):1408-15. doi: 10.1902/jop.2014.130652. Epub 2014 Feb 21.

PMID:
24555750
8.

Effect of onion flavonoids on colorectal cancer with hyperlipidemia: an in vivo study.

He Y, Jin H, Gong W, Zhang C, Zhou A.

Onco Targets Ther. 2014 Jan 8;7:101-10. doi: 10.2147/OTT.S51835. eCollection 2014.

9.

The role of simvastatin in the therapeutic approach of rheumatoid arthritis.

Cojocaru L, Rusali AC, Suţa C, Rădulescu AM, Suţa M, Craiu E.

Autoimmune Dis. 2013;2013:326258. doi: 10.1155/2013/326258. Epub 2013 Jun 12.

10.

A transcriptomics-informed genetic association study identifies RHOA in simvastatin-induced low-density lipoprotein cholesterol lowering.

Voora D.

Circ Cardiovasc Genet. 2013 Feb;6(1):137-8. doi: 10.1161/CIRCGENETICS.111.000070. No abstract available.

11.

Effects of combined treatment with simvastatin and L-carnitine on triglyceride levels in diabetic patients with hyperlipidaemia.

Brescia F, Balestra E, Iasella MG, Damato AB.

Clin Drug Investig. 2002 Nov;22(Suppl 1):23-8. doi: 10.2165/00044011-200222001-00004.

PMID:
23315432
12.

Mortality and morbidity of lowering low-density lipoprotein cholesterol with simvastatin.

Roopa S, Prabhakaran D.

Natl Med J India. 2012 Mar-Apr;25(2):90-1. No abstract available.

PMID:
22686716
13.

Hyperlipidemia after kidney transplantation: long-term graft outcome.

Raees-Jalali G, Eshraghian A, Faghihi A, Roozbeh J, Sagheb MM, Eshraghian H, Behzadi S.

Iran J Kidney Dis. 2012 Jan;6(1):49-55.

14.

Cholesterol: the good, the bad and the ugly.

Casey G.

Nurs N Z. 2011 Nov;17(10):24-9. No abstract available.

PMID:
22216624
15.

Morphological changes of parotid gland in experimental hyperlipidemia.

Daskala ID, Tesseromatis CC.

Int J Dent. 2011;2011:928386. doi: 10.1155/2011/928386. Epub 2011 Mar 21.

16.

Adherence to single-pill combination versus multiple-pill combination lipid-modifying therapy among patients with mixed dyslipidemia in a managed care population.

Kamat SA, Bullano MF, Chang CL, Gandhi SK, Cziraky MJ.

Curr Med Res Opin. 2011 May;27(5):961-8. doi: 10.1185/03007995.2011.562494. Epub 2011 Mar 7.

PMID:
21381893
17.

Severe hypocholesterolaemia is often neglected in haematological malignancies.

Pugliese L, Bernardini I, Pacifico N, Peverini M, Damaskopoulou E, Cataldi S, Albi E.

Eur J Cancer. 2010 Jun;46(9):1735-43. doi: 10.1016/j.ejca.2010.03.041. Epub 2010 Apr 29.

PMID:
20434328
18.

Efficacy and safety of ezetimibe/simvastatin association on non-diabetic and diabetic patients with polygenic hypercholesterolemia or combined hyperlipidemia and previously intolerant to standard statin treatment.

Derosa G, D'Angelo A, Franzetti IG, Ragonesi PD, Gadaleta G, Scalise F, Ciccarelli L, Piccinni MN, Cicero AF.

J Clin Pharm Ther. 2009 Jun;34(3):267-76.

PMID:
19650249
19.

Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.

Skalicka B, Kubanek M, Malek I, Vymetalova Y, Hoskova L, Podzimkova M, Kautzner J.

J Heart Lung Transplant. 2009 Jun;28(6):598-604. doi: 10.1016/j.healun.2009.03.014.

PMID:
19481021
20.

Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia.

Almutairi F, Peterson TC, Molinari M, Walsh MJ, Alwayn I, Peltekian KM.

Liver Transpl. 2009 May;15(5):504-8. doi: 10.1002/lt.21710.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk